Loading…

A head‐to‐head comparison of risankizumab and ixekizumab for genital psoriasis: a real‐life, 24‐week, prospective study

Saved in:

Bibliographic Details
Published in:	Journal of the European Academy of Dermatology and Venereology 2022-05, Vol.36 (5), p.e359-e361
Main Authors:	Sotiriou, E., Bakirtzi, K., Papadimitriou, I., Tsentemeidou, A., Eftychidou, P., Eleftheriadis, V., Lallas, A., Ioannides, D., Vakirlis, E.
Format:	Article
Language:	English
Subjects:	Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Genitalia Humans Prospective Studies Psoriasis - drug therapy Severity of Illness Index Treatment Outcome
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!